全球的微米醫療與奈米醫療:技術、應用、產業、市場 是由出版商MedMarket Diligence在2006年05月所出版的。
這份英文市場調查報告書包含250 pages, 45 Exhibits, 72 Company Profiles 價格從美金1650起跳。
專門於醫療技術、醫藥、該市場決策方案領域調查分析的美國市調公司 MedMarket Diligence (總公司:加州),針對全球的微米醫療與奈米醫療進行調查分析,特別針對技術、應用、產業、市場等主題加以系統整理並出版報告書 "Micro- and Nano-Medicine: Technologies, Applications, Industry, and Markets Worldwide" 。
本報告書內容包括:奈米科技及 MEMS 的特徵等之簡介、兩種領域的各項應用、開發情形、風險、主要市場之基礎研究等調查分析、奈米科技及 MEMS 企業的資料等。內容綱要摘記如下:
實施概要
第1章 微型世界:奈米科技
- 關於奈米科技
- 奈米科技之利用
- 奈米建築材料
- 奈米科技的缺點
- 市場中的奈米科技
- 奈米科技產業
- 奈米科技的財務情況
- MEMS
- MEMS 的一般性應用
- 材料
- 過程
- 乾式蝕刻
- MEMS 市場
- 總結
第2章 生物醫藥應用
- 奈米科技
- 癌症診斷與治療
- 藥品供應
- 診斷工具
- 各種治療標的與技術
- MEMS
- 感應器
- 加速度計
- 實驗室晶片及相關微小元件
- 胰島素幫浦
- 基礎建構
第3章 今後趨勢・調查・風險
- 今後發展前景
- 現實主義
- 奈米科技的基礎研究
- 風險因素
第4章 奈米科技及 MEMS 市場
- 奈米科技市場
- 地區市場分析
- MEMS 市場
- MEMS 加速度計
- 心臟節律器
- 體外診斷( IVD )
- 助聽器
- 化學物質感應器
第5章 奈米科技及 MEMS 產業
- 奈米企業( 86 家)
- MEMS 企業( 13 家)
附錄
Abstract
This report is a detailed assessment of the products and technologies under
development in the nanometer scale and micrometer scale levels with clinical
applications, and an assessment of the market potential for
products/technologies to be successfully commercialized for use in clinical
practice within a ten year forecast period. The report identifies the
technological, market, regulatory or other hurdles to be crossed en route to
commercialization. The report provides particular emphasis in detailing the
current activities and status of product development at active companies. The
report reveals specific opportunities for current or hopeful competitors.
Table of Contents
Section 1 Introduction
Micro- and nano-technology applications, technologies and manufacturing
processes. Differentiation between:
- MEMS technology:
- "top down" approach, using established technology in the millimetre
range to develop and manufacture devices in the mictometre range.
- Nanotechnology:
- "bottom up" approach, assembling nanoscale-devices from molecular-scale
units.
Section 2 Biomedical Applications
Established uses of extremely small technology (mainly MEMS) and potential
applications (mainly nanotech).
Current biomedical MEMS and Nanotech applications discussed will include:
- Trojan Horse drug delivery in cancer,
- Liposome-encapsulated drug delivery
- Incorporation of MEMS in pacemaker accelerometers
Advanced-stage research projects, with anticipated near-term realization, to
include:
- Nanoparticles in drug delivery
- Targeted drug delivery in cancers
- Gold nanoshells for heat-killing of cancer cells
- Cancer diagnostics
- Sensors for continuous blood glucose monitoring
- MEMS in implantable pumps (eg insulin pumps)
- Nanosensors to detect airborne pathogens
- Earlier-stage research projects, including:
- Nano-battery for artificial retina
- Artificial viruses as gene carriers
- MEMS in hearing aids and defibrillators
- Applications in biomedical research: DNA/RNA/protein analysis,
lab-on-a-chip, etc.
Section 3 Future Possibilities
Exploration of newly-emerging, and experimental uses of MEMS and
nanotechnology, including smart cancer therapies, oxygen delivery to ischaemic
tissues, smart prosthetics and implants, micro-guided surgery, whole-body
diagnostic systems, etc. Coverage of emerging and potential applications is
rooted in specific developments and successes in basic research or commercial
development (i.e., minimal emphasis on largely speculative applications).
Section 4 Market Assessment and Forecasts
This section will treat existing (established and evolving) markets separately
from speculative (i.e., potentially upcoming but not yet extant) market areas.
Five-year forecasts will be included, and separate assessments for US,
European and Japanese markets. Leading applications and companies will be
identified.
Section 5 The Nanotech and MEMS industries
Profiles of companies involved in research, development and manufacture of
nanotech- and MEMS-enabled devices, and also companies providing components
and infrastructure. These may need to be divided into MEMS and nanotechnology
sections, since the technologies, and specialisations, are fundamentally
different. It may also be necessary to divide the profiles into a priority
list of detailed profiles and a secondary list of relatively brief profiles.
Company Profiles (preliminary)
- 5.1 Nanotech Companies
- 5.1.1 Ablynx
- 5.1.2 Abraxis Bioscience
- 5.1.3 AcryMed Inc.
- 5.1.4 Acusphere Inc.
- 5.1.5 Advanced Magnetics Inc
- 5.1.6 Alltracell
- 5.1.7 AlphaRx
- 5.1.8 American Pharmaceutical Partners Inc (American Bioscience
Inc)
- 5.1.9 Anson Nano-Biotechnology Company Ltd
- 5.1.10 Angstrom Medica
- .
- .
- .
- .
- 5.1.79 Spherics Inc.
- 5.1.80 Spinelix
- 5.1.81 Starpharma Pooled Development Ltd
- 5.1.82 SurgRx Inc.
- 5.1.83 Tecan Group Ltd
- 5.1.84 Telemolecular Corporation
- 5.1.85 TransGenex Nanobiotech, Inc.
- 5.1.86 Veredus Laboratories Pte Ltd
- 5.2 MEMS Companies
- 5.2.1 Apogee Technology Inc.
- 5.2.2 Aquamarijn MicroFiltration BV
- 5.2.3 Caliper Life Sciences
- 5.2.4 CardioMEMS Inc
- .
- .
- .
- .
- 5.2.12 Silex Microsystems AB
- 5.2.13 TRONIC Microsystems S.A.
6. Appendix with company contact details
7. Glossary